Managed Entry Agreements: policy analysis from the European perspective

21 April 2020 - This article begins with a short review of the existing taxonomy of managed entry agreements and includes ...

Read more →

Could or should we use MCDA in the French HTA process?

3 December 2019 - Over the last decade, an increasing literature has been highlighting the benefits of introducing multi-criteria decision analysis ...

Read more →

Using real world data in health technology assessment (HTA) practice: a comparative study of five HTA agencies

21 March 2018 - This study examines whether real world data is incorporated in health technology assessment (HTA) of melanoma drugs ...

Read more →

The use of budget impact analysis in the economic evaluation of new medicines in Australia, England, France and the United States: relationship to cost-effectiveness analysis and methodological challenges

20 February 2018 - Good practices for budget impact analysis have been increasingly developed since the year 2000.  ...

Read more →

Agenda for the 16 September 2015 TC meeting

9 September 2015 - The agenda for the 16 September 2015 TC meeting is now available. The Commission will consider the ...

Read more →